iostony
2021-01-28
这篇文章不错,转发给大家看
国药集团拟私有化中国中药 公司停牌前涨近7%
免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP,发表看法
APP内打开
发表看法
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":311247928,"tweetId":"311247928","gmtCreate":1611805435365,"gmtModify":1703754071616,"author":{"id":3555930946631591,"idStr":"3555930946631591","authorId":3555930946631591,"authorIdStr":"3555930946631591","name":"iostony","avatar":"https://static.tigerbbs.com/c612da032eb808a4fd2ccd59c34778de","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":6,"crmLevelSwitch":1,"currentWearingBadge":{"badgeId":"35ec162348d5460f88c959321e554969-3","templateUuid":"35ec162348d5460f88c959321e554969","name":"传说交易员","description":"证券或期货账户累计交易次数达到300次","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.06.29","exceedPercentage":"93.33%","individualDisplayEnabled":0},"individualDisplayBadges":[],"fanSize":2,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body>\n这篇文章不错,转发给大家看</body></html>","htmlText":"<html><head></head><body>\n这篇文章不错,转发给大家看</body></html>","text":"这篇文章不错,转发给大家看","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/311247928","repostId":2106283432,"repostType":2,"repost":{"id":"2106283432","kind":"news","pubTimestamp":1611730020,"share":"https://www.laohu8.com/m/news/2106283432?lang=&edition=full","pubTime":"2021-01-27 14:47","market":"us","language":"zh","title":"国药集团拟私有化中国中药 公司停牌前涨近7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2106283432","media":"新浪港股","summary":"国药集团拟私有化中国中药,公司停牌前涨近7%,最新市值217亿港元。 据知情人士称,一个以国药集团为首的财团正计划将香港上市的中国中药控股有限公司私有化,对该公司的估值至少为33亿美元。 中国中药的股价去年仅上涨了2%。 一位消息人士称,国药牵头的财团计划最终让中国中药在A股上市,以利用内地股市估值较高的机会。","content":"<html><body><div>\n<p> 国药集团拟私有化<span><a href=\"https://laohu8.com/S/00570\">中国中药</a></span><span></span>,公司停牌前涨近7%,最新市值217亿港元。</p>\n<p> 据知情人士称,一个以国药集团为首的财团正计划将香港上市的中国中药控股有限公司私有化,对该公司的估值至少为33亿美元。</p>\n<p> 国药集团是中国中药的母公司和主要股东,目前正与另外两大股东——平安保险集团和中国中药董事总经理王晓春——联手,这三大股东总计持有中国中药的49.4%股份。</p>\n<p> 该财团计划对中国中药提出至少每股5.10港元的私有化报价,较该股过去一个月的平均股价溢价约33%。</p>\n<p> 中国中药的股价去年仅上涨了2%。Refinitiv的数据显示,该股的预期市盈率为9倍,远低于20倍的行业中值。</p>\n<p> 一位消息人士称,国药牵头的财团计划最终让中国中药在A股上市,以利用内地股市估值较高的机会。</p>\n<div>\n<div><img src=\"\"/></div>\n<div>海量资讯、精准解读,尽在<a href=\"https://laohu8.com/S/SINA\">新浪</a>财经APP</div>\n</div>\n<p>责任编辑:张海营 </p>\n</div></body></html>","source":"sina","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>国药集团拟私有化中国中药 公司停牌前涨近7%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n国药集团拟私有化中国中药 公司停牌前涨近7%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-01-27 14:47 北京时间 <a href=https://finance.sina.com.cn/stock/hkstock/marketalerts/2021-01-27/doc-ikftpnny2271453.shtml><strong>新浪港股</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>国药集团拟私有化中国中药,公司停牌前涨近7%,最新市值217亿港元。\n 据知情人士称,一个以国药集团为首的财团正计划将香港上市的中国中药控股有限公司私有化,对该公司的估值至少为33亿美元。\n 国药集团是中国中药的母公司和主要股东,目前正与另外两大股东——平安保险集团和中国中药董事总经理王晓春——联手,这三大股东总计持有中国中药的49.4%股份。\n 该财团计划对中国中药提出至少每股5.10港元...</p>\n\n<a href=\"https://finance.sina.com.cn/stock/hkstock/marketalerts/2021-01-27/doc-ikftpnny2271453.shtml\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/0dadac519bb6258dbafe32faf8a03d89","relate_stocks":{"00570":"中国中药"},"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2021-01-27/doc-ikftpnny2271453.shtml","is_english":false,"share_image_url":"https://static.laohu8.com/b0d1b7e8843deea78cc308b15114de44","article_id":"2106283432","content_text":"国药集团拟私有化中国中药,公司停牌前涨近7%,最新市值217亿港元。\n 据知情人士称,一个以国药集团为首的财团正计划将香港上市的中国中药控股有限公司私有化,对该公司的估值至少为33亿美元。\n 国药集团是中国中药的母公司和主要股东,目前正与另外两大股东——平安保险集团和中国中药董事总经理王晓春——联手,这三大股东总计持有中国中药的49.4%股份。\n 该财团计划对中国中药提出至少每股5.10港元的私有化报价,较该股过去一个月的平均股价溢价约33%。\n 中国中药的股价去年仅上涨了2%。Refinitiv的数据显示,该股的预期市盈率为9倍,远低于20倍的行业中值。\n 一位消息人士称,国药牵头的财团计划最终让中国中药在A股上市,以利用内地股市估值较高的机会。\n\n\n海量资讯、精准解读,尽在新浪财经APP\n\n责任编辑:张海营","news_type":1,"symbols_score_info":{"00570":1}},"isVote":1,"tweetType":1,"viewCount":1392,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":25,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/311247928"}
精彩评论